By Dr. Joseph D. Lim
The global market for dental implants is growing.
At a “stunning pace,” according to DelveInsight, a healthcare market research and business consulting company based in India and the United States.
It is valued at US$5,126.5 million in 2021 — and growing. From 2022 to 2027, it is expected to reach US$8,589.40 million by 2027, DelveInsight estimates.
Dental implant surgery is a procedure for the replacement of tooth roots with metal, screwlike posts for damaged or missing teeth. With screw-like devices, the implant is inserted into the jawbone, which acts as an anchor for an artificial tooth, called a crown.
Dental implants are made up of titanium and other materials that are compatible with the human body.
Key drivers of the implants market are the increase in tooth loss and tooth decay in old age people, bad eating habits, high sugar and carbohydrate drinks intake, poor oral hygiene, road and sports-related accidents.
The rising geriatric population, and favorable government initiatives to create awareness of good oral health, will also create a significant impact on the market.
Nearly 3.5 billion people worldwide get affected by oral diseases such as dental caries, periodontal disease, and oral-dental trauma, the World Health Organization says. Nearly two billion people suffer from caries of permanent teeth, and 520 million children suffer from caries of primary teeth.
As the number of patients suffering from tooth carriers is rising globally, the demand for dental implants also increases.
The increasing demand for cosmetic dentistry, the extended application of computer-aided design technology in implant dentistry, and increased demand for aesthetic restoration will also contribute to the market growth in the coming years, it says.
DelveInsight projects that the market for titanium implant material will reach US$7,588.97 million by 2027 owing to several advantages associated with the material.
In turn, the demand for titanium dental implants will drive the overall market growth.
However, the high cost of dental implants and reimbursement challenges leading to out-of-pocket expenses, will affect the dental implant market growth.
North America is expected to dominate the global dental implants market. The North America region is expected to reach US$3,732.08 million by 2027.
According to the United States Census Bureau (2019), nearly all American adults (96 percent) aged 65 years or older will have a cavity by 2060. One in five will have untreated tooth decay, and about two in three (68 percent) adults aged 65 years or older will have gum disease.
An increasing prevalence of dental diseases, and the growing product development activities in dental implants in the United States will also drive the market growth in the region.
The presence of a well-established infrastructure for supporting dental surgeries and the awareness among the population of oral hygiene will also stimulate the market. The increase in the number of accidents on roads or industries, workplace, or due to natural calamities, sports-related injuries, among others, lead to tooth loss, ultimately increasing the number of implantation surgeries and the product demand in the region.
All of the above will propel the North American dental implant market growth.
Global MedTech companies and technological advancements will play major roles. In April 2022, Envista Holdings Corporation announced the completion of the acquisition of Carestream Dental’s Intraoral Scanner business.
In June 2021, Neoss announced the launch of NeossONE in the United States. NeossONE is a solution unique to the Neoss Implant System — one prosthetic platform, across three implant ranges, including all implant diameters and abutments.
The leading MedTech giants in the dental implants market are Straumann AG, Dentsply Sirona, ZimVie Inc, Envista, Henry Schein, Inc, Biotech Dental, CeraRoot USA Inc, MEGA’GEN Implant Co. Ltd., Adin Dental Implant Systems Ltd., Bicon, LLC, Blue Sky Bio, TBR Dental, Cortex, Osstem, and Hiossen Implant UK, Sweden & Martina S.p.A., Biotec implant systems GmbH, Neobiotech, DentiumUSA, Neoss Limited, and Southern Implants (Pvt) Ltd. — among others.
***
Dr. Joseph D. Lim, Ed. D., is the former Associate Dean of the College of Dentistry, University of the East; former Dean, College of Dentistry, National University; Past President and Honorary Fellow of the Asian Oral Implant Academy; Honorary Fellow of the Japan College of Oral Implantologists; Honorary Life Member of the Thai Association of Dental Implantology; and Founding Chairman of the Philippine College of Oral Implantologists. For questions on dental health, e-mail jdlim2008@gmail.com or text 0917-8591515.
***
Dr. Kenneth Lester Lim, BS-MMG, DDM, MSc-OI, graduated Doctor of Dental Medicine, University of the Philippines, College of Dentistry, Manila, 2011; Bachelor of Science in Marketing Management, De la Salle University, Manila, 2002; and Master of Science (MSc.) in Oral Implantology, Goethe University, Frankfurt, Germany, 2019. He is an Associate Professor; Fellow, International Congress of Oral Implantologists; Member, American Academy of Implant Dentistry and Fellow, Philippine College of Oral Implantologists. For questions on dental health, e-mail limdentalcenter@gmail.com./WDJ